BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 28397153)

  • 1. MELDNa score is associated with psychopathology and reduced quality of life in cirrhotic patients with a liver transplant perspective.
    Cavaggioni G; Poli E; Ferri F; Parlati L; Monaco V; Melcore C; Lattanzi B; Merli M; Mennini G; Melandro F; Rossi M; Ginanni Corradini S
    Metab Brain Dis; 2017 Jun; 32(3):923-933. PubMed ID: 28397153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver Transplant Is Associated with Sustained Improvement in Tandem Gait and Risk of Falls.
    Acharya C; White MB; Fagan A; Sterling RK; Stravitz RT; Puri P; Fuchs M; Luketic V; Sanyal AJ; Wade JB; Gilles H; Heuman DM; Tinsley F; Matherly S; Lee H; Siddiqui MS; Thacker LR; Bajaj JS
    Dig Dis Sci; 2021 Apr; 66(4):1360-1366. PubMed ID: 32323075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive reserve is a determinant of health-related quality of life in patients with cirrhosis, independent of covert hepatic encephalopathy and model for end-stage liver disease score.
    Patel AV; Wade JB; Thacker LR; Sterling RK; Siddiqui MS; Stravitz RT; Sanyal AJ; Luketic V; Puri P; Fuchs M; Matherly S; White MB; Unser A; Heuman DM; Bajaj JS
    Clin Gastroenterol Hepatol; 2015 May; 13(5):987-91. PubMed ID: 25445772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychopathological profile and health-related quality of life (HRQOL) in patients with hepatocellular carcinoma (HCC) and cirrhosis.
    Palmieri VO; Santovito D; Margari F; Lozupone M; Minerva F; Di Gennaro C; Todarello O; Palasciano G
    Clin Exp Med; 2015 Feb; 15(1):65-72. PubMed ID: 24323278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life in Egyptian patients after liver transplantation.
    Mabrouk M; Esmat G; Yosry A; El-Serafy M; Doss W; Zayed N; El-Sahhar M; Awny S; Omar A
    Ann Hepatol; 2012; 11(6):882-90. PubMed ID: 23109452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a novel frailty index to predict mortality in patients with end-stage liver disease.
    Lai JC; Covinsky KE; Dodge JL; Boscardin WJ; Segev DL; Roberts JP; Feng S
    Hepatology; 2017 Aug; 66(2):564-574. PubMed ID: 28422306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between pretransplantation liver status and health-related quality of life after grafting: a single-center prospective study.
    Kotarska K; Raszeja-Wyszomirska J; Wunsch E; Chmurowicz T; Kempińska-Podhorodecka A; Wójcicki M; Milkiewicz P
    Transplant Proc; 2014 Oct; 46(8):2770-3. PubMed ID: 25380914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation.
    Lai Q; Magistri P; Lionetti R; Avolio AW; Lenci I; Giannelli V; Pecchi A; Ferri F; Marrone G; Angelico M; Milana M; Schinniná V; Menozzi R; Di Martino M; Grieco A; Manzia TM; Tisone G; Agnes S; Rossi M; Di Benedetto F; Ettorre GM;
    Liver Int; 2021 Jul; 41(7):1629-1640. PubMed ID: 33793054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transplant candidates have impaired quality of life across health domains as assessed by computerized testing.
    Stine JG; Stukenborg GJ; Wang J; Adkins A; Niccum B; Zimmet A; Argo CK
    Ann Hepatol; 2020; 19(1):62-68. PubMed ID: 31558420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the five-variable Model for End-stage Liver Disease (5vMELD) for prediction of mortality on the liver transplant waiting list.
    Myers RP; Tandon P; Ney M; Meeberg G; Faris P; Shaheen AA; Aspinall AI; Burak KW
    Liver Int; 2014 Sep; 34(8):1176-83. PubMed ID: 24256642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18.
    Biselli M; Dall'Agata M; Gramenzi A; Gitto S; Liberati C; Brodosi L; Ravaioli M; Gambato M; Montalti R; Pinna AD; Burra P; Gerunda GE; Cillo U; Andreone P; Bernardi M
    Liver Int; 2015 Jan; 35(1):184-91. PubMed ID: 24650058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superiority of the new sex-adjusted models to remove the female disadvantage restoring equity in liver transplant allocation.
    Marrone G; Giannelli V; Agnes S; Avolio AW; Baiocchi L; Berardi G; Ettorre GM; Ferri F; Corradini SG; Grieco A; Guglielmo N; Lenci I; Lionetti R; Mennini G; Milana M; Rossi M; Spoletini G; Tisone G; Manzia TM; Lai Q
    Liver Int; 2024 Jan; 44(1):103-112. PubMed ID: 37752798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is Model for End-Stage Liver Disease score associated with quality of life after liver transplantation?
    Rodrigue JR; Nelson DR; Reed AI; Hanto DW; Curry MP
    Prog Transplant; 2011 Sep; 21(3):207-14. PubMed ID: 21977881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of liver transplantation on fatigue in patients with primary biliary cirrhosis: a prospective study.
    Carbone M; Bufton S; Monaco A; Griffiths L; Jones DE; Neuberger JM
    J Hepatol; 2013 Sep; 59(3):490-4. PubMed ID: 23628322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Model for End-stage Liver Disease accurately predicts 90-day liver transplant wait-list mortality in Atlantic Canada.
    Renfrew PD; Quan H; Doig CJ; Dixon E; Molinari M
    Can J Gastroenterol; 2011 Jul; 25(7):359-64. PubMed ID: 21876856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative resource utilization and survival among liver transplant recipients with Model for End-stage Liver Disease score ≥ 40: A retrospective cohort study.
    Cardoso FS; Karvellas CJ; Kneteman NM; Meeberg G; Fidalgo P; Bagshaw SM
    Can J Gastroenterol Hepatol; 2015 May; 29(4):185-91. PubMed ID: 25965438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proposing a Sex-Adjusted Sodium-Adjusted MELD Score for Liver Transplant Allocation.
    Sealock JM; Ziogas IA; Zhao Z; Ye F; Alexopoulos SP; Matsuoka L; Chen G; Davis LK
    JAMA Surg; 2022 Jul; 157(7):618-626. PubMed ID: 35583884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying an Optimal Liver Frailty Index Cutoff to Predict Waitlist Mortality in Liver Transplant Candidates.
    Kardashian A; Ge J; McCulloch CE; Kappus MR; Dunn MA; Duarte-Rojo A; Volk ML; Rahimi RS; Verna EC; Ganger DR; Ladner D; Dodge JL; Boyarsky B; McAdams-DeMarco M; Segev DL; Lai JC
    Hepatology; 2021 Mar; 73(3):1132-1139. PubMed ID: 32491208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort.
    van Vugt JLA; Alferink LJM; Buettner S; Gaspersz MP; Bot D; Darwish Murad S; Feshtali S; van Ooijen PMA; Polak WG; Porte RJ; van Hoek B; van den Berg AP; Metselaar HJ; IJzermans JNM
    J Hepatol; 2018 Apr; 68(4):707-714. PubMed ID: 29221886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of a Scoring System That Includes Corrected QT Interval for Risk Analysis of Patients With Cirrhosis and Gastrointestinal Bleeding.
    Biselli M; Gramenzi A; Lenzi B; Dall'Agata M; Pierro ML; Perricone G; Tonon M; Bellettato L; D'Amico G; Angeli P; Boffelli S; Bonavita ME; Domenicali M; Caraceni P; Bernardi M; Trevisani F
    Clin Gastroenterol Hepatol; 2019 Jun; 17(7):1388-1397.e1. PubMed ID: 30557740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.